The ongoing Ebola outbreak may be more severe than official reports suggest, according to Oxfam. The humanitarian organization has expressed concerns about shortages of essential supplies in the central African towns at the heart of the outbreak, potentially hindering efforts to control the spread of the deadly virus.
Adding to the complexity is that this outbreak is attributed to the Bundibugyo strain of the Ebola virus, known for its rarity and high fatality rate of up to 40%. With no approved vaccines or treatments available, early detection and supportive care, such as hydration, play a critical role in improving survival chances and reducing transmission risks, highlighting the importance of access to clean water.
Field data collected by Oxfam reveals limited access to clean water in the outbreak epicenter, with sanitation and water systems deteriorating, posing a significant challenge in combating the virus. Manel Rebordosa, Oxfam’s Field Response Coordinator in Ituri province, emphasized the lack of clean water as a primary concern, noting the absence of basic sanitation facilities in mining areas and the financial burden on families to obtain clean water.
The Bundibugyo virus spreads through direct contact with infected bodily fluids like blood, saliva, or feces, making hygiene practices crucial in preventing transmission. However, Oxfam’s data indicates that only a small percentage of the population in Mongbwalu, one of the outbreak’s focal points, has access to clean water and functional sanitation facilities, potentially underestimating the outbreak’s true scale.
Oxfam warns of a potential underreporting of the outbreak’s magnitude, exacerbated by a decrease in humanitarian funding for the Democratic Republic of Congo. This reduction has forced aid agencies to limit their response efforts, exacerbating the shortage of essential supplies and services. In response, Oxfam has launched a crisis appeal to enhance its support in addressing the outbreak.
Amid these challenges, global health organizations are exploring existing Ebola treatments for effectiveness against the Bundibugyo strain. The World Health Organization (WHO) recommends prioritizing experimental drugs for treating and preventing this specific virus strain, underscoring the urgent need for a coordinated response to contain the outbreak effectively.
